Biotechnology Companies' Annual Reports & Investor Relations Material

582 Companies

BMRN

BioMarin Pharmaceutical

BioMarin Pharmaceutical Inc., a California-based biotech firm, is committed to developing and delivering innovative therapies to people with serious and life-threatening rare diseases and medical c...

BioMarin Pharmaceutical Annual Report 2023

Healthcare Biotechnology NASDAQ 1001-5000

ORMP

Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc., a New York-based biopharmaceutical company, is making strides in the development of innovative solutions for individuals with diabetes. The company's product portfolio ...

Oramed Pharmaceuticals Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

MTPH

Midatech Pharma PLC

Midatech is a pharmaceutical company with a focus on oncology and other therapeutic areas. It operates globally and has a US commercial arm that markets four cancer care supportive products, as wel...

Midatech Pharma PLC Annual Report 2020

Healthcare Biotechnology LSE 51-200

APTX

Aptinyx

Aptinyx Inc., a clinical-stage biopharmaceutical company based in Evanston, Illinois, is making waves in the medical industry with its focus on developing and commercializing novel synthetic small ...

Aptinyx Annual Report 2021

Healthcare Biotechnology NASDAQ 11-50

PACB

Pacific Biosciences of California

Pacific Biosciences of California, Inc. is a Menlo Park-based company that offers innovative solutions to resolve genetically complex problems. Its areas of focus include designing, developing, and...

Pacific Biosciences of California Annual Report 2023

Healthcare Biotechnology NASDAQ 201-500

NVH

Novoheart Holdings Inc.

Novoheart is a groundbreaking stem cell biotechnology company that has created miniature living human heart pumps for drug discovery. It is the only company in the world that has engineered such pr...

Novoheart Holdings Inc. Annual Report 2018

Healthcare Biotechnology TSX-V 11-50

GMDA

Gamida Cell Ltd.

Jerusalem-based biopharmaceutical firm Gamida Cell Ltd. is at the forefront of developing cell therapies to cure blood cancers and serious blood diseases. With its lead product candidate, omidubice...

Gamida Cell Ltd. Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

MDWD

MediWound Ltd.

Israeli-based MediWound Ltd. is making waves in the biopharmaceutical industry with its innovative, non-surgical solutions for tissue repair and regeneration. Their products are marketed globally, ...

MediWound Ltd. Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

MITO

Stealth BioTherapeutics Corp.

Stealth BioTherapeutics Corp. is a clinical-stage biotechnology company focused on finding treatments for diseases that involve mitochondrial dysfunction. Mitochondria are crucial for normal organ ...

Stealth BioTherapeutics Corp. Annual Report 2020

Healthcare Biotechnology NASDAQ 51-200

ARGX

argenx SE

Biotech firm argenx SE is making strides in the development of therapies for autoimmune diseases across the globe, with a presence in the US, the Netherlands, Belgium, Japan, Switzerland, Germany, ...

argenx SE Annual Report 2023

Healthcare Biotechnology NASDAQ 501-1000

TRVI

Trevi Therapeutics Inc

Trevi Therapeutics, a biopharmaceutical firm in the midst of clinical testing, is putting its focus squarely on the development and ultimate distribution of Haduvio. This drug is designed to provid...

Trevi Therapeutics Inc Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

HOOK

HOOKIPA Pharma

HOOKIPA Pharma Inc.: A Leader in Immunotherapeutics against Infectious Diseases and Cancers New York-based clinical stage biopharmaceutical company, HOOKIPA Pharma Inc., is riding high on the succ...

HOOKIPA Pharma Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

BDSI

BioDelivery Sciences International Inc

BioDelivery Sciences International, Inc. is a specialty pharmaceutical company in the United States which specializes in drug delivery technologies that include BEMA drug delivery technology and Bi...

BioDelivery Sciences International Inc Annual Report 2019

Healthcare Biotechnology NASDAQ 201-500

ARPO

Aerpio Pharmaceuticals, Inc.

Aerpio Pharmaceuticals is a biopharmaceutical company that is focused on developing compounds to treat ocular diseases and diabetic complications by activating Tie2. The company's lead compound, ra...

Aerpio Pharmaceuticals, Inc. Annual Report 2018

Healthcare Biotechnology NASDAQ 11-50

XENE

Xenon Pharmaceuticals

Canadian clinical-stage biopharmaceutical company, Xenon Pharmaceuticals Inc., is dedicated to developing treatments for patients with neurological disorders. The company's clinical development pip...

Xenon Pharmaceuticals Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200